Pennant Group stock analysis
Pennant Group (1ZU) Stock Price & Analysis
1ZU Stock Chart & Stats
- Day’s Range
- EUR 32.80 - EUR 35.20
- 52-Week Range
- EUR 20.20 - EUR 38.80
- Previous Close
- EUR 35.00
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 1.14B
- Enterprise Value
- EUR 1.93B
- Total Cash (Recent Filing)
- EUR 18.39M
- Total Debt (Recent Filing)
- EUR 481.15M
- Price to Earnings (P/E)
- 34.9
- Beta
- 0.25
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- 0.32
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Broad-based Growth
Strong growth across revenue, admissions, and census indicates expanding demand and effective execution in core healthcare services. Broad-based gains reduce reliance on a single operating area and provide a durable foundation for continued scale, investment, and earnings growth.
Improved Cash Generation
The shift to sustained positive free cash flow improves Pennant’s ability to fund acquisitions, infrastructure, and operations internally. Cash flow covering most reported earnings also supports earnings quality and gives management greater flexibility through changing reimbursement and cost conditions.
Leadership Development
A deep leadership pipeline can support Pennant’s decentralized operating model as the company adds locations and integrates acquisitions. Continued development of local executives should strengthen execution capacity, preserve operating culture, and support sustainable geographic expansion.
Bears Say
Recent Margin Compression
Recent margin compression suggests that revenue growth is facing higher cost pressure and producing less operating leverage. If this persists, it could limit earnings conversion, reduce the benefits of scale, and make future growth more dependent on continued execution and cost control.
Sizeable Absolute Debt
Leverage has improved, but the sizeable debt balance remains a meaningful financial obligation relative to the business. Debt service and refinancing needs can constrain capital allocation, reduce resilience during operational weakness, and limit flexibility for acquisitions or investment.
Reimbursement Pressure
Inadequate reimbursement updates can structurally pressure margins when labor and operating costs rise faster than payment rates. This is especially relevant to Pennant’s home health business, where persistent rate pressure may limit profitability and weaken the returns from service growth.
1ZU FAQ
What was Pennant Group’s price range in the past 12 months?
What is Pennant Group’s market cap?
When is Pennant Group’s upcoming earnings report date?
How were Pennant Group’s earnings last quarter?
Is Pennant Group overvalued?
Does Pennant Group pay dividends?
What is Pennant Group’s EPS estimate?
How many shares outstanding does Pennant Group have?
What happened to Pennant Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Pennant Group?
What is the TipRanks Smart Score and how is it calculated?
Pennant Group Stock Smart Score
Company Description
Pennant Group
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Brent J. Guerisoli
- Employees
- 9,700
- Website
- www.pennantgroup.com
- Address
- 1675 East Riverside Drive, Eagle, ID, 83616, US
Pennant Group (1ZU) Earnings & Revenues
1ZU Earnings Call
Earnings Call SentimentPositive
The call was positive overall, with strong revenue, EBITDA, EPS, admissions, census, clinical-quality, acquisition, and integration performance, along with reaffirmed full-year guidance. The main negatives were broad-based elevated benefits costs, short-term senior living occupancy and leadership-capacity challenges, lower Southeast home health revenue per episode, transition disruption, and management's concerns about insufficient reimbursement and regulatory burdens.
View all DE:1ZU earnings summaries1ZU Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 13 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 2 | 0 | 10 |
